A detailed history of Robeco Institutional Asset Management B.V. transactions in Exact Sciences Corp stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 27,121 shares of EXAS stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,121
Previous 34,148 20.58%
Holding current value
$1.56 Million
Previous $1.44 Million 28.02%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$42.43 - $70.83 $298,155 - $497,722
-7,027 Reduced 20.58%
27,121 $1.85 Million
Q2 2024

Jul 22, 2024

SELL
$41.33 - $74.26 $3.25 Million - $5.83 Million
-78,538 Reduced 69.7%
34,148 $1.44 Million
Q1 2024

Apr 24, 2024

SELL
$56.27 - $73.77 $988,157 - $1.3 Million
-17,561 Reduced 13.48%
112,686 $7.78 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $2.47 Million - $3.17 Million
41,895 Added 47.42%
130,247 $9.64 Million
Q4 2023

Feb 08, 2024

SELL
$59.06 - $75.72 $746,813 - $957,479
-12,645 Reduced 12.52%
88,352 $130 Million
Q3 2023

Oct 23, 2023

BUY
$65.94 - $99.04 $3.74 Million - $5.62 Million
56,774 Added 128.38%
100,997 $6.89 Million
Q2 2023

Jul 24, 2023

SELL
$62.68 - $95.05 $741,253 - $1.12 Million
-11,826 Reduced 21.1%
44,223 $4.15 Million
Q1 2023

May 03, 2023

BUY
$47.19 - $70.77 $661,745 - $992,407
14,023 Added 33.37%
56,049 $3.8 Million
Q4 2022

Feb 06, 2023

BUY
$30.35 - $53.15 $1.12 Million - $1.96 Million
36,949 Added 727.77%
42,026 $2.08 Million
Q3 2022

Dec 01, 2022

BUY
$31.97 - $49.37 $24,393 - $37,669
763 Added 17.69%
5,077 $165,000
Q3 2022

Oct 26, 2022

BUY
$31.97 - $49.37 $24,393 - $37,669
763 Added 17.69%
5,077 $165,000
Q1 2022

Dec 01, 2022

BUY
$57.56 - $82.54 $245,953 - $352,693
4,273 Added 10421.95%
4,314 $302,000
Q1 2022

Apr 26, 2022

BUY
$57.56 - $82.54 $245,953 - $352,693
4,273 Added 10421.95%
4,314 $302,000
Q4 2021

Dec 01, 2022

SELL
$72.5 - $100.68 $39,005 - $54,165
-538 Reduced 92.92%
41 $3,000
Q4 2021

Jan 31, 2022

BUY
$72.5 - $100.68 $2,972 - $4,127
41 New
41 $3,000
Q3 2021

Oct 20, 2021

SELL
$90.24 - $124.05 $52,248 - $71,824
-579 Closed
0 $0
Q2 2021

Dec 01, 2022

SELL
$93.66 - $139.27 $243,422 - $361,962
-2,599 Reduced 81.78%
579 $72,000
Q2 2021

Jul 28, 2021

SELL
$93.66 - $139.27 $243,422 - $361,962
-2,599 Reduced 81.78%
579 $72,000
Q1 2021

Dec 01, 2022

SELL
$116.57 - $155.01 $221,366 - $294,363
-1,899 Reduced 37.4%
3,178 $418,000
Q1 2021

Apr 23, 2021

BUY
$116.57 - $155.01 $302,965 - $402,870
2,599 Added 448.88%
3,178 $418,000
Q4 2020

Dec 01, 2022

SELL
$99.61 - $142.12 $448,045 - $639,255
-4,498 Reduced 88.6%
579 $77,000
Q4 2020

Jan 28, 2021

BUY
$99.61 - $142.12 $57,674 - $82,287
579 New
579 $77,000
Q3 2020

Oct 29, 2020

SELL
$72.92 - $102.01 $36,460 - $51,005
-500 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$55.75 - $92.75 $27,875 - $46,375
500 New
500 $43,000
Q1 2020

Apr 30, 2020

SELL
$37.9 - $104.44 $104,566 - $288,149
-2,759 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$77.66 - $99.74 $736,527 - $945,934
-9,484 Reduced 77.46%
2,759 $255,000
Q3 2019

Oct 17, 2019

BUY
$90.37 - $122.49 $1.11 Million - $1.5 Million
12,243 New
12,243 $1.11 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.